Rifogal

CAS: 6998-60-3

Ref. 3D-GAA99860

Produktinformation

• Name: Rifogal
• Synonyme: (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv., 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-, 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, Nsc 133100, Rifamicina, Rifamicine SV, Rifampin SV, Rifamycin SV, Rifamycin SV MMX, Rifamycine, Rifocin, Rifocine, Rifomycin, Rifomycin SV, Riphogal, [2S-(2R*,12Z,14E,16R*,17R*,18S*,19S*,20S*,21R*,22S*,23R*,24E)]-21-(Acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione

Beschreibung

Rifogal is a rifamycin that is used to treat bacterial infections. It is an antibiotic that binds to DNA-dependent RNA polymerase, preventing transcription and replication. Rifogal has been shown to be effective against infections caused by Gram-positive bacteria, including Mycoplasma hominis and Streptococcus pneumoniae. In addition, this drug has been shown to have anti-inflammatory properties as it inhibits the toll-like receptor TLR4 pathway and reduces acute toxicities such as bowel disease and insect resistance.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 697.8 g/mol
• Formel: C₃₇H₄₇NO₁₂
• Reinheit: Min. 95%